FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, namely combustiology, plastic surgery, cosmetology, and can find application as a bioplastic material for skin defect replacement and regeneration stimulation. What is described is a micro-nanostructured bioplastic material which is based on a nanostructured matrix formed of hyaluronic acid; it contains proteoglycans, glycoproteins, fibrous proteins and antiseptic in the following ratio (per 100 ml): hyaluronic acid - 30-20; proteoglycans - 20-30; glycoproteins -10-15, fibrous proteins - 10-15, antiseptic - 5-10; solvent (water) - the rest.
EFFECT: higher clinical effectiveness of the bioplastic material ensured by the accelerated process of tissue regeneration.
1 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
HISTO-EQUIVALENT BIOPLASTIC MATERIAL | 2013 |
|
RU2513838C1 |
NANOSTRUCTURED BIOPLASTIC MATERIAL | 2010 |
|
RU2425694C1 |
BIOLOGICAL MATERIAL ALLOPLANT USABLE IN RECONSTRUCTIVE SURGERY | 2001 |
|
RU2189257C1 |
METHOD OF RECOVERY OF DEFECTS OF COVERING TISSUES | 2016 |
|
RU2644306C1 |
BIOPLASTIC MATERIAL | 2008 |
|
RU2367476C1 |
COSMETIC SKIN | 2013 |
|
RU2528899C1 |
ORGAN-SPECIFIC BIOPLASTIC MATERIAL BASED ON SOLUBLE FORM OF STABILIZED EXTRACELLULAR MATRIX | 2019 |
|
RU2722744C1 |
XENOGENIC BIOMATERIAL FOR REGENERATIVE SURGERY | 2009 |
|
RU2440148C2 |
METHOD OF TREATING DEFECTS OF SKIN AND SOFT TISSUES IN PATIENTS WITH DIABETES MELLITUS AND METHOD OF INTRODUCTION OF DRUG THEREFOR | 2017 |
|
RU2679449C1 |
BIOLOGICALLY ACTIVE MATERIAL FOR COVERING WOUND SURFACES | 2022 |
|
RU2804197C1 |
Authors
Dates
2013-05-10—Published
2012-02-21—Filed